Pipeline

Our DARPin^® platform has vast applicability across a range of diseases. Explore our pipeline:

Candidate (Targets)

Research

Preclinical

Phase 1

Phase 2

Phase 3

Rights

Ensovibep for COVID-19

Phase 3

MP0423 for COVID-19

Preclinical

AMG 506 (MP0310) / FAP x 4-1BB

Phase 1

MP0317 / FAP x CD-40

Preclinical

AML CD33 x CD70 x CD123 x CD3

Preclinical

Abicipar for nAMD

Phase 3

Abicipar for DME

Phase 2

Platform Discovery Areas

T-Cell Engagers

Preclinical

Additional Infectious Diseases

Research